Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection

Table 2 Mean values (± SD) of aspartate aminotransferase-to-alanine aminotransferase ratio, aspartate aminotransferase-to-platelet ratio index, age platelet index, cirrhosis discriminating score and Göteborg University Cirrhosis Index in non-cirrhotic and cirrhotic groups of chronic hepatitis C virus infected patients

Variable	Non-cirrhotic group (F0, F1, F2 and F3), n (124)	Cirrhotic group (F4), n (30)	P value
AAR	0.84 ± 0.31	1.23 ± 0.47	0.001
APRI	0.078 ± 0.09	0.118 ± 0.07	0.02
API	2.98 ± 2.21	5.87 ± 1.99	0.0001
CDS	5.48 ± 1.36	6 ± 1.31	0.17
GUCI	0.913 ± 1.27	1.6573 ± 0.89	0.001
Pohl score	+ve 12 (9.67%)	+ve 12 (40%)	0.004
	-ve 112 (90.3%)	-ve 18 (60%)

AAR: Aspartate aminotransferase-to-alanine aminotransferase ratio; APRI: Aspartate aminotransferase-to-platelet ratio index; API: Age platelet index; CDS: Cirrhosis discriminating score; GUCI: Göteborg University Cirrhosis Index.